S. 92 · 115th Congress
Safe and Affordable Drugs from Canada Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
McCainSponsor10 cosponsors · 8 D, 1 R, 1 I
D
Klobuchar
CG
R
Grassley
SB
D
Brown
AK
I
King
PL
D
Leahy
SW
D
Whitehouse
TB
D
Baldwin
JM
D
Merkley
JS
D
Shaheen
MH
D
Hassan1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 185 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that:
What it does: CRS summary · Introduced in Senate · Jan 10, 2017
Safe and Affordable Drugs from Canada Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 185 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that:
- is dispensed by a pharmacist licensed in Canada;
- is purchased for personal use in quantities not greater than a 90-day supply;
- is filled using a valid prescription issued by a physician licensed to practice in the United States; and
- has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved under the FFDCA.
Certain medications may not be imported, including controlled substances and biological products.
The bill establishes a certification process for approving Canadian pharmacies. HHS must publish a list of approved Canadian pharmacies.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Safe and Affordable Drugs from Canada Act of 2017
Latest action (Jan 10, 2017): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Jan 10, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.